Live tape
Top 8, mentions 7d9,540TSLA2,006 mentions▲ +0.05GOOGL1,548 mentions▲ +0.05NVDA1,168 mentions▲ +0.07CRWV1,148 mentions▲ +0.03SPCX1,036 mentions▲ +0.07QQQ1,010 mentions▲ +0.04META818 mentions▲ +0.05NBIS806 mentions▲ +0.05

Equity · Healthcare

CTEV

NYSE

Claritev Corporation

$24 −1.34% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 13, 2026
Price · Chart
36 sessions
$50 $20 21 Jul 13 Oct

The line runs $28.71 on 21 July through $24 on 13 October, on a scale from $20 to $50. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 36 sessions, 21 Jul – 13 Oct 2026
Market cap $406.7M
52-week range $13 – $72
Avg volume 7.2K

as of Oct 13, 2026

CTEV insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Oct 2026
Open-market buys 2
Open-market sells 4
Net sold $808K
Non-trade filings 4
Date Insider Type Shares Value
15 Oct 2026 Misencik Tiffani SVP, Chief Growth Officer Sell 5,812 $138K
21 Sep 2026 Garis Douglas Michael EVP&CFO Sell 9,025 $276K
28 Aug 2026 Dalton Travis Pres., CEO & Executive Chair Buy 1,950 $75K
27 Aug 2026 Dalton Travis Pres., CEO & Executive Chair Buy 4,500 $175K
14 Aug 2026 Misencik Tiffani SVP, Chief Growth Officer Sell 8,850 $355K
10 Aug 2026 Mintz William B. SVP, Chief Strategy Officer Sell 8,431 $289K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Oct 2026 Misencik Tiffani SVP, Chief Growth Officer Tax withheld 9,994 $239K
14 Sep 2026 Letham Thomas Benjamin Director Award 2,880
05 Aug 2026 Garis Douglas Michael EVP&CFO Tax withheld 11,711 $306K
05 Aug 2026 Mintz William B. SVP, Chief Strategy Officer Tax withheld 3,622 $95K

CTEV reported financials

SEC EDGAR XBRL SEC EDGAR

CTEV reported revenue of $965.4M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$284.3M.

Figure Reported Period
Revenue $965.4M 31 Dec 2025 fiscal year
Net income −$284.3M 31 Dec 2025 fiscal year
Diluted EPS −$17.30 31 Dec 2025 fiscal year
Total assets $4.8B 30 Jun 2026 at period end
Total equity −$294.6M 30 Jun 2026 at period end

CTEV earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$3.49 $257M
31 Mar 2026 Q1 2026 −$4.41 $245M
31 Dec 2025 FY 2025 −$17.30 $965M
30 Sep 2025 Q3 2025 −$4.23 $246M
30 Jun 2025 Q2 2025 −$3.81 $242M
31 Mar 2025 Q1 2025 −$4.38 $231M
31 Dec 2024 FY 2024 −$101.92 $931M
30 Sep 2024 Q3 2024 −$24.25 $230M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CTEV institutional holders

SEC Form 13F SEC EDGAR

6 of the 45 institutional funds we track reported a CTEV position for the quarter ended 30 Jun 2026 — a combined $10.0M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Added +398.7% shares 174,011 $5.9M
Renaissance Technologies Held (±25%) −11.4% shares 46,015 $1.6M
Point72 Asset Management Trimmed −56.4% shares 39,000 $1.3M
Marshall Wace Trimmed −80.9% shares 13,533 $462K
Millennium Management Trimmed −48.7% shares 9,936 $339K
D. E. Shaw & Co. New position 9,580 $327K
Third Point Exited

CTEV fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 258 shares of CTEV failed to deliver (about $6K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 258 $6K 0.002%
23 Sep 2026 269,686 $7.9M 1.591%
15 Sep 2026 15,487 $564K 0.091%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings